MimiVax announces disappointing pivotal Phase IIb trial data for cancer vaccine
Even before this readout, KOLs were not excited about MimiVax's cancer vaccine in interviews with GlobalData.
Even before this readout, KOLs were not excited about MimiVax's cancer vaccine in interviews with GlobalData.